 |
市場調查報告書
商品編碼
2008185
生物製藥生產一次性系統市場：依生物反應器、應用、生物製程、產品、模式、組件和地區分類Single Use System in Biopharma Manufacturing Market, By Bioreactors, By Application, By Bioprocessing, By Product, By Modality, By Component, By Geography |
||||||
價格
簡介目錄
預計到 2026 年，生物製藥生產的一次性系統市場規模將達到 180 億美元，到 2033 年將達到 683.5 億美元。預計 2026 年至 2033 年的複合年成長率將達到 20.8%。
| 分析範圍 | 分析詳情 | ||
|---|---|---|---|
| 基準年 | 2025 | 市場規模（2026 年） | 180億美元 |
| 效能數據 | 2020-2024 | 預測期 | 2026-2033 |
| 預測期（2026-2033 年）複合年成長率 | 20.80% | 預計金額（2033 年） | 683.5億美元 |
一次性使用系統（SUS）是指專為一次性使用和處置而設計的生物製藥生產設備。這些系統正日益成為生物製藥生產中不銹鋼設備的替代方案。一次性使用技術為生物製藥的生產提供了一種高效且經濟的方式。簡而言之，一次性使用系統和技術為滿足生物製藥研發和生產中的生物製程需求提供了解決方案。例如，全球生物製藥公司正在採用一次性使用系統來生產藥品和疫苗。
市場動態
政府對生物相似藥和生技藥品的支持力度加大，生物製藥的接受度和需求不斷提高，生物製藥能夠治療難治性疾病，以及生物製藥製造業的成長，這些都是推動全球生物製藥生產一次性系統市場成長的主要因素。
2021 年 2 月，百時美施貴寶授予洛克斐勒獨家許可，開發、生產和商業化一種新型單株抗體雙療法，用於中和 SARS-CoV-2 病毒，以治療或預防 COVID-19。
此外，2020 年 3 月，賽默飛世爾科技投資約 4.75 億美元，用於擴大其生技藥品、細胞療法、基因療法和藥物開發設施，並增強其全球商業能力。
本報告的主要特點
- 本報告指出了各個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
- 此外，它還提供了有關市場促進因素和限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要企業採取的競爭策略的重要見解。
- 本節根據以下參數介紹全球生物製藥生產一次性系統市場中主要企業的概況：公司概況、產品系列、主要亮點、財務表現和策略。
- 本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、產品線更新、市場擴張和行銷策略做出明智的決策。
- 《全球生物製藥生產一次性系統市場》報告面向該行業的各種相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
- 相關人員可以透過分析全球生物製藥生產一次性系統市場中使用的各種策略矩陣來促進決策。
目錄
第1章：分析目標與假設
- 分析目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
- Coherent Opportunity Map（COM）
第3章：市場動態、監管與趨勢分析
- 市場動態
- 全球對生物製藥的需求不斷成長
- 先進製造要求
- 對安全有效藥品和疫苗的需求日益成長
- 影響分析
- 主要亮點
- 法規環境
- 產品上市及核准
- PEST分析
- 波特五力分析
- 企業合併趨勢
第4章：全球生物製藥生產一次性系統市場：依生物反應器分類（2026-2033 年）
- 小於1000公升
- 1000～2000L
- 超過2000公升
第5章：全球生物製藥生產一次性系統市場：按應用領域分類（2026-2033 年）
- 過濾
- 儲存（緩衝溶液和培養基的儲存、冷凍和解凍）
- 細胞培養
- 混合物
- 純化
- 無菌灌裝
第6章：全球生物製藥生產一次性系統市場：依生物製程分類（2026-2033 年）
- 小規模
- 中號
- 大規模
第7章 全球生物製藥生產一次性系統市場：依產品分類（2026-2033 年）
- 採樣系統
- 生物製程容器
- 生物反應器
- 混合器
- 膜吸收器
- 瓶子
- 裝置
- 傳輸單元
- 其他物品（一次性濾芯（DFC）、深層過濾器、夾具等）
第8章：全球生物製藥生產一次性系統市場：按模式分類（2026-2033 年）
- 蛋白質、單株抗體（Mab）
- 細胞療法
- 基因治療
- 傳統疫苗
- mRNA
第9章：全球生物製藥生產用一次性系統市場：按組件分類（2026-2033 年）
- 原料藥
- 配方
第10章：全球生物製藥生產用一次性系統市場：按地區分類（2026-2033 年）
- 北美洲
- 美國
- 加拿大
- 歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 俄羅斯
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太地區
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
- 中東和非洲
- GCC
- 以色列
- 南非
- 中非
- 其他中東和非洲地區
- 其他地區（ROW）
第11章 競爭格局
- Getinge AB
- Rentschler Biopharma SE
- Kuhner AG
- Danaher Corporation
- Merck KgaA
- Lonza
- PBS Biotech Inc.
- ThermoFisher Scientific
- Corning Incorporated
- Eppendorf
- Entegris
- Pall Corporation
- Sartorius AG（Sartorius Stedim Biotech）
第12章
- 分析方法
- 關於 Coherent Market Insights
簡介目錄
Product Code: CMI5228
Single Use System In Biopharma Manufacturing Market is estimated to be valued at USD 18,000 Mn in 2026 and is expected to reach USD 68,350 Mn by 2033, growing at a compound annual growth rate (CAGR) of 20.8% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 18,000 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 20.80% | 2033 Value Projection: | USD 68,350 Mn |
Single use systems (SUS) refers to biopharmaceutical manufacturing equipment designed to be used once and then discarded. These systems are being increasingly used as an alternative to stainless-steel equipment for biopharma manufacturing. Single-use technologies offer both efficient & cost-effective way to manufacture biopharmaceuticals. In short, single use systems or technologies provide solutions that address the bioprocessing needs in the development and manufacturing of biopharmaceuticals. For instance, biopharmaceutical companies worldwide use single-use system to manufacture drugs and vaccines.
Market Dynamics
Rising government support towards biosimilar & biological drugs, increasing acceptance and demand for biopharmaceuticals, ability of biopharmaceuticals to treat untreatable diseases, and growing biopharmaceutical manufacturing industry are some major factors expected to aid in the growth of the global single use system in biopharma manufacturing market.
In February 2021, Bristol Myers Squibb granted an exclusive license to develop, manufacture, and commercialize Rockefeller's novel monoclonal antibody duo treatment that neutralizes the SARS-CoV-2 virus for therapy or prevention of COVID-19.
Moreover, in March 2020, Thermo Fisher Scientific Inc. invested around US$ 475 million to expand its biologics, cell therapy and gene therapy, and drug product development facilities and increase its global commercial capabilities.
Key features of the study
- This report provides in-depth analysis of the global single use system in biopharma manufacturing market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global single use system in biopharma manufacturing market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Getinge AB, Rentschler Biopharma SE, Kuhner AG, Danaher Corporation, Merck KgaA, Lonza, PBS Biotech Inc., ThermoFisher Scientific, Corning Incorporated, Eppendorf, Pall Corporation, Entegris, and Sartorius AG (Sartorius Stedim Biotech), among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global single use system in biopharma manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global single use system in biopharma manufacturing market.
Market Segmentation
- By Bioreactors
- Less than 1000L
- 1000-2000L
- More than 2000L
- By Application
- Filtration
- Storage (Buffer & Media Storage, Freeze & Thaw)
- Cell Culture
- Mixing
- Purification
- Aseptic Filling
- By Bioprocessing
- Small-scale
- Mid-scale
- Large-scale
- By Product
- Sampling Systems
- Bioprocess Containers
- Bioreactors
- Mixers
- Membrane Absorbers
- Bottles
- Equipment
- Transfer Units
- Others (Disposable filter Cartridges (DFC), Depth Filters, Clamps etc.)
- By Modality
- Protein & Monoclonal Antibody (Mab)
- Cell Therapy
- Gene Therapy
- Conventional Vaccine
- mRNA
- By Component
- Drug Substance
- Drug Product
- By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players
- Getinge AB
- Rentschler Biopharma SE
- Kuhner AG
- Danaher Corporation
- Merck KgaA
- Lonza
- PBS Biotech Inc.
- ThermoFisher Scientific
- Corning Incorporated
- Eppendorf
- Pall Corporation
- Entegris
- Sartorius AG (Sartorius Stedim Biotech)
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Bioreactors
- Market Snippet, By Application
- Market Snippet, By Bioprocessing
- Market Snippet, By Product
- Market Snippet, By Modality
- Market Snippet, By Component
- Market Snippet, By Geography
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Increasing demand for biopharmaceuticals across the globe
- High-end manufacturing requirements
- Increasing demand for safe and effective drugs and vaccines
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Single Use System in Biopharma Manufacturing Market, By Bioreactors, 2026-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Less than 1000L
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
- 1000-2000L
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
- More than 2000L
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
5. Global Single Use System in Biopharma Manufacturing Market, By Application, 2026-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Filtration
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
- Storage (Buffer & Media Storage, Freeze & Thaw)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
- Cell Culture
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
- Mixing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
- Purification
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
- Aseptic Filling
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
6. Global Single Use System in Biopharma Manufacturing Market, By Bioprocessing, 2026-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Small-scale
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
- Mid-scale
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
- Large-scale
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
7. Global Single Use System in Biopharma Manufacturing Market, By Product, 2026-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Sampling Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
- Bioprocess Containers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
- Bioreactors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
- Mixers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
- Membrane Absorbers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
- Bottles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
- Equipment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
- Transfer Units
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
- Others (Disposable filter Cartridges (DFC), Depth Filters, Clamps etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
8. Global Single Use System in Biopharma Manufacturing Market, By Modality, 2026-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Protein & Monoclonal Antibody (Mab)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
- Cell Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
- Gene Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
- Conventional Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
- mRNA
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
9. Global Single Use System in Biopharma Manufacturing Market, By Component, 2026-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Drug Substance
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
- Drug Product
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
10. Global Single Use System in Biopharma Manufacturing Market, By Geography, 2026-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Bioreactors, 2026-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Bioprocessing, 2026-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Modality, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2026-2033, (USD Mn)
- US
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Bioreactors, 2026-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Bioprocessing, 2026-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Modality, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2026-2033, (USD Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Bioreactors, 2026-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Bioprocessing, 2026-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Modality, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2026-2033, (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Bioreactors, 2026-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Bioprocessing, 2026-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Modality, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2026-2033, (USD Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East and Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Bioreactors, 2026-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Bioprocessing, 2026-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Modality, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2026-2033, (USD Mn)
- GCC
- Israel
- South Africa
- Central Africa
- Rest of Middle East and Africa
- Rest of World
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Bioreactors, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Bioprocessing, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Modality, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2026-2033, (USD Mn)
11. Competitive Landscape
- Getinge AB
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Rentschler Biopharma SE
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Kuhner AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Danaher Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck KgaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Lonza
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- PBS Biotech Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- ThermoFisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Corning Incorporated
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Eppendorf
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Entegris
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pall Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sartorius AG (Sartorius Stedim Biotech)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Analyst Views
12. Section
- Research Methodology
- About us
